A citation-based method for searching scientific literature

Serena Notartomaso, Harumi Nakao, Giada Mascio, Pamela Scarselli, Milena Cannella, Cristina Zappulla, Michele Madonna, Marta Motolese, Roberto Gradini, Francesca Liberatore, Micaela Zonta, Giorgio Carmignoto, Giuseppe Battaglia, Valeria Bruno, Masahiko Watanabe, Atsu Aiba, Ferdinando Nicoletti. Sci Rep 2018
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The role of inflammation in schizophrenia.
Norbert Müller, Elif Weidinger, Bianka Leitner, Markus J Schwarz. Front Neurosci 2015
208
100

Metabotropic glutamate receptors: from the workbench to the bedside.
F Nicoletti, J Bockaert, G L Collingridge, P J Conn, F Ferraguti, D D Schoepp, J T Wroblewski, J P Pin. Neuropharmacology 2011
399
100

Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.
Terrell Holloway, José L Moreno, Adrienne Umali, Vinayak Rayannavar, Georgia E Hodes, Scott J Russo, Javier González-Maeso. J Neurosci 2013
84
100

The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia.
R S Devon, S Anderson, P W Teague, W J Muir, V Murray, A J Pelosi, D H Blackwood, D J Porteous. Mol Psychiatry 2001
67
100

D-aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices.
Gemma Molinaro, Sara Pietracupa, Luisa Di Menna, Lorenzo Pescatori, Alessandro Usiello, Giuseppe Battaglia, Ferdinando Nicoletti, Valeria Bruno. Neurosci Lett 2010
22
100

Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.
Hyekyung P Cho, Pedro M Garcia-Barrantes, John T Brogan, Corey R Hopkins, Colleen M Niswender, Alice L Rodriguez, Daryl F Venable, Ryan D Morrison, Michael Bubser, J Scott Daniels,[...]. ACS Chem Biol 2014
35
100

Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor.
Tetsuaki Hiyoshi, Toshiyuki Marumo, Hirohiko Hikichi, Yasumitsu Tomishima, Hiroki Urabe, Tomoko Tamita, Izumi Iida, Akito Yasuhara, Jun-ichi Karasawa, Shigeyuki Chaki. J Pharmacol Exp Ther 2014
22
100

A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models.
Gene G Kinney, Julie A O'Brien, Wei Lemaire, Maryann Burno, Denise J Bickel, Michelle K Clements, Tsing-Bau Chen, David D Wisnoski, Craig W Lindsley, Philip R Tiller,[...]. J Pharmacol Exp Ther 2005
244
100

Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.
Francesco Matrisciano, Patricia Tueting, Stefania Maccari, Ferdinando Nicoletti, Alessandro Guidotti. Neuropsychopharmacology 2012
85
100


Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Giuseppe Battaglia, Barbara Riozzi, Domenico Bucci, Luisa Di Menna, Gemma Molinaro, Simone Pallottino, Ferdinando Nicoletti, Valeria Bruno. Neurobiol Dis 2015
32
100

Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Francesco Fazio, Cristina Zappulla, Serena Notartomaso, Carla Busceti, Alban Bessede, Pamela Scarselli, Carmine Vacca, Marco Gargaro, Claudia Volpi, Massimo Allegrucci,[...]. Neuropharmacology 2014
35
100


Targeting metabotropic glutamate receptors for the treatment of neuroinflammation.
Francesco Fazio, Martina Ulivieri, Claudia Volpi, Marco Gargaro, Francesca Fallarino. Curr Opin Pharmacol 2018
20
100

Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia.
Corrado Corti, Luca Crepaldi, Silvia Mion, Adelheid L Roth, John H Xuereb, Francesco Ferraguti. Biol Psychiatry 2007
62
100

Identification of a serotonin/glutamate receptor complex implicated in psychosis.
Javier González-Maeso, Rosalind L Ang, Tony Yuen, Pokman Chan, Noelia V Weisstaub, Juan F López-Giménez, Mingming Zhou, Yuuya Okawa, Luis F Callado, Graeme Milligan,[...]. Nature 2008
550
100


The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia.
Carlo Maj, Alessandra Minelli, Edoardo Giacopuzzi, Emilio Sacchetti, Massimo Gennarelli. Curr Neuropharmacol 2016
9
100

Parvalbumin neurons and perineuronal nets in the mouse prefrontal cortex.
Hiroshi Ueno, Shunsuke Suemitsu, Motoi Okamoto, Yosuke Matsumoto, Takeshi Ishihara. Neuroscience 2017
39
100

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.
Jeffrey R Bishop, Vicki L Ellingrod, Jessica Moline, Del Miller. Schizophr Res 2005
61
100

Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.
Harry Pantazopoulos, Tsung-Ung W Woo, Maribel P Lim, Nicholas Lange, Sabina Berretta. Arch Gen Psychiatry 2010
177
100

Serotonin model of schizophrenia: emerging role of glutamate mechanisms.
G K Aghajanian, G J Marek. Brain Res Brain Res Rev 2000
336
100

Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects.
Mitul A Mehta, Anne Schmechtig, Vasileia Kotoula, Juliet McColm, Kimberley Jackson, Claire Brittain, Sitra Tauscher-Wisniewski, Bruce J Kinon, Paul D Morrison, Thomas Pollak,[...]. Psychopharmacology (Berl) 2018
15
100


Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
Agnieszka Nikiforuk, Piotr Popik, Karla U Drescher, Marcel van Gaalen, Ana-Lucia Relo, Mario Mezler, Gerard Marek, Hans Schoemaker, Gerhard Gross, Anton Bespalov. J Pharmacol Exp Ther 2010
57
100


Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.
B A Fijal, B J Kinon, S Kapur, V L Stauffer, R R Conley, H H Jamal, J M Kane, M M Witte, J P Houston. Pharmacogenomics J 2009
54
100

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators.
Samantha E Yohn, Daniel J Foster, Dan P Covey, Mark S Moehle, Jordan Galbraith, Pedro M Garcia-Barrantes, Hyekyung P Cho, Michael Bubser, Anna L Blobaum, Max E Joffe,[...]. Mol Psychiatry 2020
12
100

No evidence for association between polymorphisms in GRM3 and schizophrenia.
Nadine Norton, Hywel J Williams, Sarah Dwyer, Dobril Ivanov, Anna C Preece, Amy Gerrish, Nigel M Williams, Pamela Yerassimou, Stanley Zammit, Michael C O'Donovan,[...]. BMC Psychiatry 2005
40
100


The selective mGluR5 agonist CHPG attenuates SO2-induced oxidative stress and inflammation through TSG-6/NF-κB pathway in BV2 microglial cells.
Jun-Ling Qiu, Wen-Li Zhu, Yu-Jie Lu, Zheng-Fa Bai, Zhi-Gang Liu, Pei Zhao, Chao Sun, Ya-Bin Zhang, Hua Li, Wei Liu. Neurochem Int 2015
15
100

Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.
F Fazio, L Lionetto, G Molinaro, H O Bertrand, F Acher, R T Ngomba, S Notartomaso, M Curini, O Rosati, P Scarselli,[...]. Mol Pharmacol 2012
51
100


mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
Hoau-Yan Wang, Mathew L MacDonald, Karin E Borgmann-Winter, Anamika Banerjee, Patrick Sleiman, Andrew Tom, Amber Khan, Kuo-Chieh Lee, Panos Roussos, Steven J Siegel,[...]. Mol Psychiatry 2020
17
100

Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase.
David J Loane, Bogdan A Stoica, Ahdeah Pajoohesh-Ganji, Kimberly R Byrnes, Alan I Faden. J Biol Chem 2009
85
100


Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.
Guillermo Gonzalez-Burgos, Raymond Y Cho, David A Lewis. Biol Psychiatry 2015
267
100

Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population.
N Aoyama, N Takahashi, S Saito, N Maeno, R Ishihara, X Ji, H Miura, M Ikeda, T Suzuki, T Kitajima,[...]. Genes Brain Behav 2006
36
100

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
Gene G Kinney, Maryann Burno, Una C Campbell, Lisa M Hernandez, Dana Rodriguez, Linda J Bristow, P Jeffrey Conn. J Pharmacol Exp Ther 2003
181
100

Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.
Luisa Di Menna, Max E Joffe, Luisa Iacovelli, Rosamaria Orlando, Craig W Lindsley, Jèrome Mairesse, Pierre Gressèns, Milena Cannella, Filippo Caraci, Agata Copani,[...]. Neuropharmacology 2018
50
100

Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders.
S A Barnes, A Pinto-Duarte, A Kappe, A Zembrzycki, A Metzler, E A Mukamel, J Lucero, X Wang, T J Sejnowski, A Markou,[...]. Mol Psychiatry 2015
49
100

Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
Yo Fujii, Hiroki Shibata, Rumiko Kikuta, Chieko Makino, Ayako Tani, Naotsugu Hirata, Atsushi Shibata, Hideaki Ninomiya, Nobutada Tashiro, Yasuyuki Fukumaki. Psychiatr Genet 2003
91
100


Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
780
100

Disruption of prepulse inhibition in mice lacking mGluR1.
S A Brody, F Conquet, M A Geyer. Eur J Neurosci 2003
68
100

Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review.
M O Trépanier, K E Hopperton, R Mizrahi, N Mechawar, R P Bazinet. Mol Psychiatry 2016
176
100

Association analysis of the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia.
Jeffrey R Bishop, Kai Wang, Jessica Moline, Vicki L Ellingrod. Psychiatr Genet 2007
15
100

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.
Korrapati V Sathyasaikumar, Erin K Stachowski, Ikwunga Wonodi, Rosalinda C Roberts, Arash Rassoulpour, Robert P McMahon, Robert Schwarcz. Schizophr Bull 2011
155
100

A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population.
Qi Chen, Guang He, Qingying Chen, Shengnan Wu, Yifeng Xu, Guoyin Feng, Yucheng Li, Lijun Wang, Lin He. Schizophr Res 2005
68
100

Positive allosteric modulators (PAMs) of metabotropic glutamate receptor 5 (mGluR5) attenuate microglial activation.
Fengtian Xue, Bogdan A Stoica, Marie Hanscom, Shruti V Kabadi, Alan I Faden. CNS Neurol Disord Drug Targets 2014
15
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.